Timothy J. Atkinson, PharmD, BCPS, CPE

Clinical Pharmacy Specialist, Pain ManagementVA Tennessee Valley Health Care System

Timothy John Atkinson, PharmD, BCPS, CPE, is currently a Clinical Pharmacy Specialist, Pain Management at the VA Tennessee Valley Healthcare System. Dr. Atkinson specializes in complex and high-risk pain medication management through direct patient care and electronic consult services within the regional referral pain clinic. He serves as co-chair of the TVHS Opioid Safety Initiative (OSI) Taskforce and he is the Residency Director for the PGY-2 Pain and Palliative Care Residency program at TVHS. His research interests include opioid equivalencies, serum level monitoring, pain management in specialty disease states, and the elderly.

Disclosures: Consultant/independant Contractor: Axial Healthcare Inc.

Related

Opioid Management

Opioid Peptides: A Review of Natural Substances with Opioid Effects

Jessica Geiger, PharmD, MS, BCPS; Jeffrey J. Bettinger, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

This review goes beyond poppies to the world of non-opiate opioid peptides, comparing their physio-chemical and pharmacologic profiles, and discussing their potential for future development and use in pain management.

Opioid Management

Opioid Peptides: A Review of Natural Substances with Opioid Effects

Jessica Geiger, PharmD, MS, BCPS; Jeffrey J. Bettinger, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

This review goes beyond poppies to the world of non-opiate opioid peptides, comparing their physio-chemical and pharmacologic profiles, and discussing their potential for future development and use in pain management.

Analgesics & Pain Medications

Special Report: Return of the NSAIDs

Claire Brandt, PharmD, BCPS; Lauren Bell, PharmD, BCPS; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

Latest data and recommendations for NSAID use for chronic pain management, perioperative pain, bone healing, and more.

Analgesics & Pain Medications

Special Report: Return of the NSAIDs

Claire Brandt, PharmD, BCPS; Lauren Bell, PharmD, BCPS; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

Latest data and recommendations for NSAID use for chronic pain management, perioperative pain, bone healing, and more.

Analgesics & Pain Medications

Topical Anti-Inflammatories: Analgesic Options for Arthritis Beyond NSAIDs

Hannah Thorfinnson, PharmD; Shawn Dalton, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

Topical diclofenac gel, arnica, sesame, and comfrey provide holistic treatment alternatives to NSAIDs for reducing inflammatory pain, knee pain, osteoarthritic pain.

Analgesics & Pain Medications

Topical Anti-Inflammatories: Analgesic Options for Arthritis Beyond NSAIDs

Hannah Thorfinnson, PharmD; Shawn Dalton, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

Topical diclofenac gel, arnica, sesame, and comfrey provide holistic treatment alternatives to NSAIDs for reducing inflammatory pain, knee pain, osteoarthritic pain.

Analgesics & Pain Medications

Peripheral Kappa Opioid Receptor Agonists

Rebekka L Burch, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

FDA designated breakthrough therapy difelikefalin/CR845 (Korsuva) from Cara Therapeutics may change approaches to treating inflammatory pain as well as chronic kidney disease-associated pruritis.

Analgesics & Pain Medications

Peripheral Kappa Opioid Receptor Agonists

Rebekka L Burch, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

FDA designated breakthrough therapy difelikefalin/CR845 (Korsuva) from Cara Therapeutics may change approaches to treating inflammatory pain as well as chronic kidney disease-associated pruritis.

Opioid Management

Cebranopadol as an Opioid Alternative

Timothy J. Atkinson, PharmD, BCPS, CPE; Holly H. Cowley, PharmD, BCPS

Journal Article

Based on the pharmacology and pharmacokinetics, cebranopadol appears to be a promising alternative to traditional opioids. Inside the data.

Opioid Management

Cebranopadol as an Opioid Alternative

Timothy J. Atkinson, PharmD, BCPS, CPE; Holly H. Cowley, PharmD, BCPS

Journal Article

Based on the pharmacology and pharmacokinetics, cebranopadol appears to be a promising alternative to traditional opioids. Inside the data.

Analgesics & Pain Medications

G-Protein Biased Mu-Opioid Receptor Ligands

Carla Figura, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

A review of the new analgesic oliceridine (Olinvyk, Trevena) and the class of G-protein biased mu-opioid receptor ligands for pain management.

Analgesics & Pain Medications

G-Protein Biased Mu-Opioid Receptor Ligands

Carla Figura, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

A review of the new analgesic oliceridine (Olinvyk, Trevena) and the class of G-protein biased mu-opioid receptor ligands for pain management.

Medication Management

Inside the Potential of Nerve Growth Factor Antagonists

M. Tatjana A. Ramos, PharmD, MPH; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

A review of the pipeline nerve growth factor (NGF) inhibitors tanezumab (Pfizer, Eli Lilly) and fasinumab (Regeneron, Teva).

Medication Management

Inside the Potential of Nerve Growth Factor Antagonists

M. Tatjana A. Ramos, PharmD, MPH; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

A review of the pipeline nerve growth factor (NGF) inhibitors tanezumab (Pfizer, Eli Lilly) and fasinumab (Regeneron, Teva).

Addiction Medicine

A Comparison of the Alpha-2-Adrenergic Receptor Agonists for Managing Opioid Withdrawal

Meredith W. Crumb, PharmD, BCPS; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

A review and comparison of the alpha-2-adrenergic receptor agonists Lofexidine and Clonidine for the management of opioid withdrawal after abrupt discontinuation.

Addiction Medicine

A Comparison of the Alpha-2-Adrenergic Receptor Agonists for Managing Opioid Withdrawal

Meredith W. Crumb, PharmD, BCPS; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

A review and comparison of the alpha-2-adrenergic receptor agonists Lofexidine and Clonidine for the management of opioid withdrawal after abrupt discontinuation.

Kratom: Miracle Medicine or Herb of Abuse?

Carla Figura, PharmD; Monica Barrett, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

Kratom could be clinically beneficial for pain management and substance use disorders. What clinicians need to know.

Kratom: Miracle Medicine or Herb of Abuse?

Carla Figura, PharmD; Monica Barrett, PharmD; Timothy J. Atkinson, PharmD, BCPS, CPE

Journal Article

Kratom could be clinically beneficial for pain management and substance use disorders. What clinicians need to know.

Pain Management

Assessment and Monitoring of Pain: Urine Drug Screening

Timothy J. Atkinson, PharmD, BCPS, CPE; Jeffrey Fudin, PharmD, FCCP, FASHP; Jeff Gudin, MD

Urine drug screen interpretations as part of drug monitoring in chronic pain management and opioid prescribing.

Pain Management

Assessment and Monitoring of Pain: Urine Drug Screening

Timothy J. Atkinson, PharmD, BCPS, CPE; Jeffrey Fudin, PharmD, FCCP, FASHP; Jeff Gudin, MD

Urine drug screen interpretations as part of drug monitoring in chronic pain management and opioid prescribing.

Pain Management

Urine Drug Screen and When to Order More Tests

Timothy J. Atkinson, PharmD, BCPS, CPE; Jeffrey Fudin, PharmD, FCCP, FASHP; Jeff Gudin, MD

Learn more about the different urine drug tests available, and when to order more tests in patients who test positive for a medication not prescribed.

Pain Management

Urine Drug Screen and When to Order More Tests

Timothy J. Atkinson, PharmD, BCPS, CPE; Jeffrey Fudin, PharmD, FCCP, FASHP; Jeff Gudin, MD

Learn more about the different urine drug tests available, and when to order more tests in patients who test positive for a medication not prescribed.

Pain Management

Where Did the War on Pain Go Wrong?

Timothy J. Atkinson, PharmD, BCPS, CPE; Jennifer H. Scruggs, RN, MSN, ANP-BC; Tracey L. Perkins, RN, MSN, FNP-C

Over the last 30 years, there has been a therapeutic shift in the use of opioids for pain management. Learn more about how we are entering a new era of awareness about the potential risks and benefits of opioid medications.

Pain Management

Where Did the War on Pain Go Wrong?

Timothy J. Atkinson, PharmD, BCPS, CPE; Jennifer H. Scruggs, RN, MSN, ANP-BC; Tracey L. Perkins, RN, MSN, FNP-C

Over the last 30 years, there has been a therapeutic shift in the use of opioids for pain management. Learn more about how we are entering a new era of awareness about the potential risks and benefits of opioid medications.